MYCOBACTERIUM ABSCESSUS INFECTION
Clinical trials for MYCOBACTERIUM ABSCESSUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new MYCOBACTERIUM ABSCESSUS INFECTION trials appear
Sign up with your email to follow new studies for MYCOBACTERIUM ABSCESSUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to beat tough lung bug
Disease control Not yet recruitingThis study tests a new mix of antibiotics (called Arm D) against standard treatments for a rare, hard-to-treat lung infection caused by mycobacterium abscessus. About 300 people, with or without cystic fibrosis, will take the new combo for 4 weeks or standard care for 6 weeks. Re…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Viruses vs. superbugs: new hope for drug-resistant lung disease?
Disease control Not yet recruitingThis early study tests a special virus cocktail (phages) given alongside standard antibiotics to fight a chronic, drug-resistant lung infection caused by Mycobacterium abscessus. The goal is to see if the treatment can reduce bacteria in the lungs and improve breathing. Only one …
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE1 • Sponsor: Alberta Health services • Aim: Disease control
Last updated May 04, 2026 16:30 UTC